← Back to Search

Values-based mindfulness group for Depression (REVAMP Trial)

Phase 1 & 2
Waitlist Available
Led By June P Tangney, PhD
Research Sponsored by George Mason University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week post-treatment and 3 months post-release
Awards & highlights

REVAMP Trial Summary

This is a pilot study to examine the acceptability and effectiveness of the Re-Entry Values and Mindfulness Program (REVAMP), a group intervention for jail inmates. It is hypothesized that REVAMP will reduce post-release recidivism, substance abuse, and HIV risk behavior.

Eligible Conditions
  • Depression
  • Impulsivity
  • Substance Abuse
  • Risky Behaviors
  • Anxiety
  • Criminogenic Thinking

REVAMP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week post-treatment and 3 months post-release
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week post-treatment and 3 months post-release for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability - number of participants who report finding the treatment helpful and number who would recommend the treatment to a friend
HIV Risk Behavior - Sex and Intravenous Drug Use (IDU) - TCU
Recidivism - Official Records of arrests
+3 more
Secondary outcome measures
Distress-Driven Impulsivity - Behavioral measure using Balloon Analog Reaction Test (BART) preceded by mirror tracing task
Mindfulness - Self report using Mindfulness Inventory: Nine Dimensions (MI:ND)
Psychological Symptoms - Self report using Personality Assessment Inventory
+2 more

REVAMP Trial Design

2Treatment groups
Experimental Treatment
Group I: Values-based mindfulness groupExperimental Treatment1 Intervention
The Re-entry values and mindfulness program (REVAMP) is an 8 session group intervention designed for jail inmates nearing release into the community
Group II: Treatment as usualExperimental Treatment1 Intervention
has access to standard jail interventions and programs
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TAU
2016
Completed Phase 3
~8350

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

George Mason UniversityLead Sponsor
58 Previous Clinical Trials
48,754 Total Patients Enrolled
June P Tangney, PhDPrincipal InvestigatorGeorge Mason University
1 Previous Clinical Trials
150 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates
June Tangney 2011. "Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01378923.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top